Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH.
Center for Value-Based Care Research, Medicine Institute, Department of Medicine, Cleveland Clinic, Cleveland, OH.
Crit Care Med. 2020 Jul;48(7):e611-e619. doi: 10.1097/CCM.0000000000004377.
Extracorporeal cardiopulmonary resuscitation has shown survival benefit in select patients with refractory cardiac arrest but there is insufficient data on the frequency of different types of brain injury. We aimed to systematically review the prevalence, predictors of and survival from neurologic complications in patients who have undergone extracorporeal cardiopulmonary resuscitation.
MEDLINE (PubMed) and six other databases (EMBASE, Cochrane Library, CINAHL Plus, Web of Science, and Scopus) from inception to August 2019.
Randomized controlled trials and observational studies in patients greater than 18 years old.
Two independent reviewers extracted the data. Study quality was assessed by the Cochrane Risk of Bias tool for randomized controlled trials, the Newcastle-Ottawa Scale for cohort and case-control studies, and the Murad tool for case series. Random-effects meta-analyses were used to pool data.
The 78 studies included in our analysis encompassed 50,049 patients, of which 6,261 (12.5%) received extracorporeal cardiopulmonary resuscitation. Among extracorporeal cardiopulmonary resuscitation patients, the median age was 56 years (interquartile range, 52-59 yr), 3,933 were male (63%), 3,019 had out-of-hospital cardiac arrest (48%), and 2,289 had initial shockable heart rhythm (37%). The most common etiology of cardiac arrest was acute coronary syndrome (n = 1,657, 50% of reported). The median extracorporeal cardiopulmonary resuscitation duration was 3.2 days (interquartile range, 2.1-4.9 d). Overall, 27% (95% CI, 0.17-0.39%) had at least one neurologic complication, 23% (95% CI, 0.14-0.32%) hypoxic-ischemic brain injury, 6% (95% CI, 0.02-0.11%) ischemic stroke, 6% (95% CI, 0.01-0.16%) seizures, and 4% (95% CI, 0.01-0.1%) intracerebral hemorrhage. Seventeen percent (95% CI, 0.12-0.23%) developed brain death. The overall survival rate after extracorporeal cardiopulmonary resuscitation was 29% (95% CI, 0.26-0.33%) and good neurologic outcome was achieved in 24% (95% CI, 0.21-0.28%).
One in four patients developed acute brain injury after extracorporeal cardiopulmonary resuscitation and the most common type was hypoxic-ischemic brain injury. One in four extracorporeal cardiopulmonary resuscitation patients achieved good neurologic outcome. Further research on assessing predictors of extracorporeal cardiopulmonary resuscitation-associated brain injury is necessary.
体外心肺复苏术已显示在某些难治性心脏骤停患者中具有生存获益,但关于不同类型脑损伤的频率仍缺乏足够的数据。本研究旨在系统回顾接受体外心肺复苏术患者的神经并发症的患病率、预测因素和生存率。
从建库到 2019 年 8 月,我们在 MEDLINE(PubMed)和其他 6 个数据库(EMBASE、Cochrane 图书馆、CINAHL Plus、Web of Science 和 Scopus)中进行了检索。
大于 18 岁患者的随机对照试验和观察性研究。
两名独立的审查员提取了数据。使用 Cochrane 偏倚风险工具评估随机对照试验的研究质量,使用 Newcastle-Ottawa 量表评估队列和病例对照研究的质量,使用 Murad 工具评估病例系列研究的质量。使用随机效应荟萃分析对数据进行汇总。
纳入分析的 78 项研究共纳入 50049 例患者,其中 6261 例(12.5%)接受了体外心肺复苏术。体外心肺复苏术患者的中位年龄为 56 岁(四分位距,52-59 岁),3933 例为男性(63%),3019 例为院外心脏骤停(48%),2289 例为初始可除颤性心律(37%)。心脏骤停最常见的病因是急性冠状动脉综合征(n=1657,占报告病因的 50%)。体外心肺复苏术的中位持续时间为 3.2 天(四分位距,2.1-4.9 天)。总体而言,27%(95%可信区间,0.17-0.39%)至少发生了 1 次神经并发症,23%(95%可信区间,0.14-0.32%)发生了缺氧缺血性脑损伤,6%(95%可信区间,0.02-0.11%)发生了缺血性卒中,6%(95%可信区间,0.01-0.16%)发生了癫痫发作,4%(95%可信区间,0.01-0.1%)发生了脑出血。17%(95%可信区间,0.12-0.23%)发生了脑死亡。体外心肺复苏术的总体生存率为 29%(95%可信区间,0.26-0.33%),24%(95%可信区间,0.21-0.28%)获得了良好的神经结局。
体外心肺复苏术后,每 4 例患者中就有 1 例发生急性脑损伤,最常见的类型是缺氧缺血性脑损伤。每 4 例体外心肺复苏术患者中就有 1 例获得了良好的神经结局。需要进一步研究评估体外心肺复苏术相关脑损伤的预测因素。